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Abstract
Inherited ataxias are characterized by degeneration of the cerebellar structures, which results in progressive motor
incoordination. Hereditary ataxias occur in many species, including humans and dogs. Several mutations have been found
in humans, but the genetic background has remained elusive in dogs. The Finnish Hound suffers from an early-onset
progressive cerebellar ataxia. We have performed clinical, pathological, and genetic studies to describe the disease
phenotype and to identify its genetic cause. Neurological examinations on ten affected dogs revealed rapidly progressing
generalized cerebellar ataxia, tremors, and failure to thrive. Clinical signs were present by the age of 3 months, and
cerebellar shrinkage was detectable through MRI. Pathological and histological examinations indicated cerebellum-
restricted neurodegeneration. Marked loss of Purkinje cells was detected in the cerebellar cortex with secondary changes in
other cortical layers. A genome-wide association study in a cohort of 31 dogs mapped the ataxia gene to a 1.5 Mb locus on
canine chromosome 8 (praw = 1.1610
27, pgenome = 7.5610
24). Sequencing of a functional candidate gene, sel-1 suppressor
of lin-12-like (SEL1L), revealed a homozygous missense mutation, c.1972T.C; p.Ser658Pro, in a highly conserved protein
domain. The mutation segregated fully in the recessive pedigree, and a 10% carrier frequency was indicated in a population
cohort. SEL1L is a component of the endoplasmic reticulum (ER)–associated protein degradation (ERAD) machinery and has
not been previously associated to inherited ataxias. Dysfunctional protein degradation is known to cause ER stress, and we
found a significant increase in expression of nine ER stress responsive genes in the cerebellar cortex of affected dogs,
supporting the pathogenicity of the mutation. Our study describes the first early-onset neurodegenerative ataxia mutation
in dogs, establishes an ERAD–mediated neurodegenerative disease model, and proposes SEL1L as a new candidate gene in
progressive childhood ataxias. Furthermore, our results have enabled the development of a genetic test for breeders.
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Introduction
Ataxia is a neurological symptom of defective motor coordina-
tion that can affect gait, balance, speech and gaze [1]. Human
hereditary ataxias are rare heterogeneous disorders characterized
by progressive degeneration of the cerebellum and cerebellar
connections, with a variable degree of involvement from extra-
cerebellar structures [2]. The predominant inheritance patterns
are autosomal dominant and autosomal recessive [1]. Unlike the
autosomal dominant spinocerebellar ataxias (SCAs), which usually
affect the central nervous system (CNS), the recessive disorders
involve more often other organs [1]. Typical age of onset for
dominant ataxias is between 30 to 50 years of age [3], whereas the
recessive forms tend to have an onset before the age of 20 years
[4].
Causative mutations have been identified for at least 19 different
dominant SCAs, most of which are caused by repeat expansions
[5,6]. In recessive human ataxias, the number of known disease
genes is somewhere around 20, depending on the classification
criteria [2,7–10]. Described pathological mechanisms are diverse but
include some common themes, such as accumulation of protein
aggregates, defects in the DNA-repair system, mitochondrial
dysfunction and oxidative stress [1,2,9,11]. In addition to the known
human ataxia genes, several spontaneous mutations that cause
cerebellar degeneration have been recognized in mice [12–14].
Cerebellar degeneration has also been described in several dog
breeds [15–30]. In veterinary medicine, the disease group is referred
to as cerebellar cortical abiotrophies (CCAs), where abiotrophy
describes the idiopathic premature neuronal degeneration [31].
Clinical signs in canine CCAs include ataxia, dysmetria, tremors,
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broad-based stance and loss of balance, all of which contribute to the
often significant ambulatory difficulties [32,33]. Majority of the
described canine phenotypes are early-onset and manifest by the age
of 3 to 4 months [16,17,19–23,25,27,28]. Later-onset and slowly
progressing CCAs are less common but occur in some breeds
[18,24,26]. In a classical CCA, pathological findings are focused on
the cerebellar cortex where the primary degenerative change is the
loss of cortical Purkinje cells (PCs), followed by secondary changes in
granular and molecular cell layers [32,33]. Primary degeneration of
cortical granule cells is seen more rarely [27,29]. Involvement of CNS
structures other than the cerebellum has been reported in some
breeds, for instance in Kerry Blue Terriers [16] and Brittany Spaniels
[24]. A more systemic phenotype is seen in the Bernese Mountain
Dog, where cerebellar degeneration is accompanied by a hepatic
degeneration [23]. In Rhodesian Ridgebacks, affected dogs present
with a diluted coat color [22]. Collectively, the variability in disease
onset, severity and histopathological details indicate a heterogeneous
genetic etiology across different breeds. Although autosomal recessive
inheritance has been proposed in several breeds [16,18,26,30], the
underlying genetic causes of canine primary ataxias have remained
largely unidentified. Thus far, a molecular characterization has been
reported only in a rare type of neonatal ataxia in Coton De Tulear
dogs that have a mutation in the GRM1 glutamate receptor gene [34].
Additionally, a putative CCA locus has been recently mapped to
canine chromosome 3 (CFA3) in Australian Kelpies [35].
In the present study, we have examined clinical and genetic
characteristics of hereditary ataxia that affects the Finnish Hound
(FH) dog breed. A previous case report has indicated an early-onset
progressive cerebellar neurodegeneration in a FH puppy [15]. We
provide a more comprehensive clinical picture in a larger sample
cohort and identify a recessive mutation in a novel ataxia gene.
Results
Clinical examinations indicate generalized cerebellar
ataxia
Ten affected FH puppies from six different litters were referred
to a veterinary neurology clinic for general clinical, orthopedical
and neurological examinations (Table 1). One healthy littermate
was examined as a control dog. At the time of examination,
affected puppies were from 3 to 4 months old. The clinical signs
were first noticed at a mean age of 9 weeks, ranging from 4 to 12
weeks (Table 1). General clinical and orthopedical examination
did not reveal any significant changes. Neurological examinations
were strongly indicative of cerebellar dysfunction by revealing
generalized cerebellar ataxia with dysmetria (Video S1), postural
reaction deficits (Video S2) and intention tremor (Video S3).
Cranial and spinal nerve reflexes were normal, and all affected
dogs had normal cognition. Serum biochemistry profiles, complete
blood cell count (CBC) and cerebrospinal fluid (CSF) cell count
were within normal limits in all affected dogs. For an undefined
reason, protein concentration was mildly elevated in one affected
puppy. All ten affected puppies were euthanized because of a rapid
disease progression and poor prognosis.
MRI and histopathological examinations reveal cerebellar
neurodegeneration
Cerebellar pathology was supported by magnetic resonance
imaging (MRI) and post-mortem examinations. Nine out of ten
affected puppies showed reduced cerebellar size on T1- and T2-
weighted (T1W and T2W) midsagittal brain MRI scans (Figure 1).
No changes were detected in the cerebrum or brainstem. General
pathological examination did not reveal any significant gross
changes outside the CNS. The weight of the cerebellum relative to
the total brain mass was measured in five dogs and ranged from
8.1 to 9.7%. This indicated a loss of cerebellar mass as the normal
proportion of the cerebellum is $10% [32]. A few disease
nonspecific histological findings were made; a mild interstitial
pneumonia was seen in four dogs and mild follicular hyperplasia in
the spleen of three dogs.
Histological changes of the nervous system were restricted to the
cerebellum in all examined puppies. The cerebellar cortex showed
marked premature degeneration and loss of PCs with consequent
neuronal depletion in the granular cell layer (Figure 2B and 2D).
The cerebellar vermis and the paramedian lobule were consis-
tently the most severely affected areas. The cranial regions of the
cerebellar cortex were more affected than the caudal regions. The
ventrolateral parts, including paraflocculi and flocculus, were
spared and partially normal (Figure 2A and 2C). In the cortical
areas, where severe PC loss was present, glial cells (Bergmans glia)
were proliferating between the molecular and the granular cell
layers (Figure 2D). The remaining PCs were shrunken and
eosinophilic with marginated nuclear chromatin or showed total
loss of cytoplasmic basophilic Nissl substance (chromatolysis)
(Figure 2E and 2F). The granular cell layer was markedly depleted
of neurons and showed mild astrocytosis in areas of profound PCs
loss (Figure 2G). Occasional degenerated and vacuolated axons
were detected in the granular layer. Mild to moderate ongoing
degeneration and myelinophagia was seen within the cerebellar
white matter of the severely affected areas (Figure 2H). Neither
transsynaptic degeneration in the cerebellar nuclei nor retrograde
degeneration of the olivary nucleus was found. Immunohisto-
chemical (IHC) staining for canine distemper virus and parvovirus
showed no positivity. The overall severity of the histopathological
findings, including active PC degeneration, total granule cell and
PC loss, consecutive white matter lesions and the extent of the
lesions, are summarized in Table 1.
Genetic studies map a novel recessive ataxia locus
A pedigree was established around the known affected FH
puppies to determine the most likely mode of inheritance
(Figure 3). According to the pedigree data, all affected dogs were
Author Summary
Hereditary ataxias are a heterogeneous group of rare
disorders characterized by progressive cerebellar neuro-
degeneration. Several causative mutations have been
identified in various forms of human ataxias. In addition
to humans, inherited ataxias have been described in
several other species, including the domestic dog. In this
study, we have studied the clinical and genetic properties
of cerebellar ataxia in the Finnish Hound dog breed. The
breed suffers from a progressive ataxia that has an early
onset before the age of 3 months. Affected puppies have
difficulties in coordinating their movements and balance,
and have to be euthanized due to rapidly worsening
symptoms. Our pedigree analysis suggested an autosomal
recessive mode of inheritance, which was confirmed by
identifying a homozygous mutation in the SEL1L gene
through genome-wide association and linkage analyses.
The SEL1L protein functions in a protein quality control
pathway that targets misfolded proteins to degradation in
the endoplasmic reticulum. Mutations in the SEL1L gene
have not been previously found in ataxias. Our study
indicates SEL1L as a novel candidate gene for human
childhood ataxias, establishes a large animal model to
investigate mechanisms of cerebellar neurodegeneration,
and enables carrier screening for breeding purposes.
SEL1L Mutation in Canine Cerebellar Ataxia
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born from healthy parents, both sexes were affected and the
proportion of affected puppies across litters was 29%, near the
expected 25%. These observations were consistent with an
autosomal recessive mode of inheritance.
We first used a candidate gene approach to try to identify the
causative gene. Altogether 24 known human and murine ataxia
genes were selected (Table S1), and the segregation of microsat-
ellite markers, within or adjacent to the candidate genes, was
studied in three nuclear families. Each family included both parent
dogs and at least one affected and one healthy offspring. No co-
segregation was observed between any of the markers and the
disease.
We subsequently proceeded to map the FH ataxia locus by
using a genome-wide approach. A cohort of 31 dogs, comprising
13 cases, 11 obligate carrier parents and seven non-affected
siblings, were genotyped using Illumina’s 22K canine SNP chip. A
standard case-control association test was carried out on the 13
cases and seven full-sibling controls by using PLINK software
[36]. This revealed a genome-wide significant association on
CFA8 with two SNPs, BICF2P948919 and BICF2P754995, that
had the best nominal and corrected p-values of praw = 1.1610
27
and pgenome = 7.5610
24 (Figure 4A). The association results were
confirmed by utilizing a joint family-based linkage and association
analysis program PSEUDOMARKER [37]. The joint analysis,
which was carried out on the associated CFA8 using the entire
genotyped sample cohort, identified the same locus and a single
most significant SNP, BICF2P948919 (LOD score = 3.3, associ-
ation p = 2.261027 and joint analysis p = 4.0610210) (Figure 4B).
Assessment of genotypes at the associated CFA8 locus revealed
a shared 1.5 Mb homozygous haplotype block in affected dogs,
spanning from 56.0 to 57.5 Mb (Figure 4C). All genotyped parent
dogs were carriers of this disease haplotype. Within the 1.5 Mb
block, only the most significant SNP, BICF2P948919, showed
complete segregation with the disease, indicating that the
causative variant probably lies in its vicinity. The 1.5 Mb
haplotype contained seven genes. Two of these, LOC100687147
(serine/threonine-protein kinase Nek6-like) and LOC612107
(uncharacterized hypothetical gene) were likely pseudogenes.
The other five were known protein-coding genes, centrosomal
protein 128kDa (CEP128), thyroid stimulating hormone receptor
(TSHR), general transcription factor IIA (GTF2A1), stoning 2
(STON2) and sel-1 suppressor of lin-12-like (SEL1L) (Figure 4D).
We ranked SEL1L as the best candidate gene for mutation
screening due to its neuronal expression, and function in a protein
degradation pathway in the endoplasmic reticulum (ER) [38–41].
Impaired protein degradation is a common feature in several
neurodegenerative diseases [42,43]. In addition, the fully segre-
gating SNP, BICF2P948919, was located on the second intron of
the SEL1L gene. Besides SEL1L, the STON2 gene was considered a
plausible causative gene because of its neuronal function in
synaptic vesicle recycling at presynaptic nerve terminals [44–47].
Exonic sequencing identifies a missense mutation in the
SEL1L gene
The coding regions of the five known protein coding genes were
sequenced in two affected puppies and in two obligate carrier
parents in order to identify possible disease-causing mutations. No
sequence variants that segregated with the phenotype were found
in TSHR or GTF2A1. Sequencing of STON2 and CEP128 revealed
a few segregating variants but none of them were in the coding
regions (Table S2). In SEL1L, we identified altogether four coding
and 19 non-coding variants, all of which segregated with the
disease (Table S2). Three of the exonic variants were synonymous
but one was a non-synonymous cytosine to thymine change on
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exon 19 (c.1972T.C) that results in a serine to proline alteration
at position 658 of the encoded protein (p.Ser658Pro) (Figure 4E).
The c.1972T.C variant was genotyped in the full sample cohort
and showed complete segregation and a 100% penetrance with the
disease. All 13 affected puppies were homozygous for the T.C
change, all 13 parents heterozygous and 20 littermates either
heterozygous (12 out of 20) or wild-type (8 out of 20). Segregation
of the variant was further validated by genotyping altogether 241
randomly selected unaffected FHs. None of these population
controls were homozygous for the C allele but a 10% carrier
frequency (24/241) was indicated. Segregation analysis gave a
highly significant association between the C allele and disease
(p = 1.8610242). Moreover, the c.1972T.C allele was completely
absent in 349 dogs from 51 other breeds (Table S3), including a
Russian hound breed, which is related to FHs. We later received a
sample from a newly affected FH puppy from Finland that was
found homozygous for the CC genotype. Another suspected FH
ataxia puppy from Sweden was tested free of the mutation.
However, further inquiries of this puppy’s phenotype revealed that
it had not presented with clinical signs typical for FH ataxia but
had in reality suffered from an episodic disorder. The puppy could
not be examined further as it had been euthanized at 6 weeks of
age.
The probability of the SEL1L p.Ser658Pro change having a
pathogenic effect was evaluated by utilizing bioinformatics tools.
SEL1L is a transmembrane glycoprotein that resides in the
endoplasmic reticulum (ER) [48,49]. The carboxy-terminus of the
protein harbors the transmembrane domain and amino-terminal
protein body is exposed to the ER lumen. The lumenal protein
body is composed of a single fibronectin type II domain and three
clusters of tetratricopeptide repeat (TPR)-like motifs, the Sel1-
repeats (Figure 5A) [39,40,49,50]. The p.Ser658Pro amino acid
change is positioned in one out of the several Sel1-repeat motifs of
the protein (Figure 5A). We found Ser658 to be fully conserved in
all aligned vertebrates, insects and in the hemichordate acorn
worm. Only C. elegans’s orthologue Sel1 and yeast’s orthologue
Hrd3p differed at the position (Figure 5B). Moreover, three
sequence homology-based prediction tools, PANTHER, PolyPhen
and SIFT, all predicted the Ser658Pro change to have a probably
damaging effect on protein function (PANTHER SubPSEC
score =25.4, PolyPhen-2 (HumVar-trained) score = 0.98 and the
SIFT score = 0.02).
According to various expression databases, mammalian SEL1L
is ubiquitously expressed. However, we wanted to specifically
confirm SEL1L cerebellar expression and also to see, if the non-
synonymous c.1972T.C variant has an effect on SEL1L mRNA
stability. Amplification and sequencing of the entire SEL1L
transcript confirmed cerebellar expression, the presence of the
mutation at mRNA level and the predicted exon/intron bound-
aries, and finally, excluded the possible splicing effects of the
several identified intronic variants (Table S2). Real-time quanti-
fication of the SEL1L transcript in cerebellar cortical tissue samples
of five affected dogs and a control puppy revealed a 2.8-fold
increase in the affected dogs (Figure 6A). We also studied the
cerebellar expression of the two other genes with segregating non-
coding variants, STON2 and CEP12, but did not find differences in
their transcript levels between the control and affected dogs
(Figure 6A).
Upregulation of ER stress genes in affected cerebellar
cortex
SEL1L is a component of an ER-associated protein complex
that functions in protein degradation [38–41]. Impaired protein
degradation is known to affect ER homeostasis and result in ER
Figure 1. Brain MRI scans. Sagittal midline T2W brain MRI images of a normal and affected Finnish Hounds. (A) A control dog with normal
cerebellum (arrow). (B) An affected dog that has smaller cerebellar size and increased cerebrospinal fluid space (white) between the cerebellum and
the occipital bone ventrally (arrow). (C) An affected dog that shows reduced cerebellar size and increase in the fluid filled space in the area of the
fourth ventricle (arrow). (D) Another affected dog that has reduced cerebellar size and increased fluid filled spaces between the cerebellar folia
(arrows).
doi:10.1371/journal.pgen.1002759.g001
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Figure 2. Histological findings within the cerebellar cortex of affected dogs. (A) Normal cerebellar cortex in the ventrolateral parts of the
cerebellum, with densely cellular granular cell layer (HE 1006). (B) Affected cerebellar cortex in the vermal region with marked loss of granular cells
(HE 1006). (C) A higher magnification of unaffected cortex with viable Purkinje cells (PCs) and a normal granular cell density (HE 4006). (D) A higher
magnification of affected cortex, with severe loss of PCs and linear reactive gliosis between the molecular and the granular layers (arrow) (HE 4006).
(E) Degenerating, shrunken, eosinophilic PCs with margination of the nuclear chromatin (black arrow) or central chromatolysis of the cytoplasma (red
arrow) (HE 4006). (F) PCs that show total loss of cytoplasmic basophilia (Nissl substance) and pyknotic or karyorhektic nuclei (arrows). Inset: viable PC
with intact Nissl substance seen as basophilic cytoplasmic granulation (LFB-CEV, 4006). (G) Left: mild astrogliosis (arrows) within the granular cell
layer and the white matter of the cerebellar folia. Right: unaffected part of same dog (IHC GFAP, 4006). (H) Left: secondary degeneration and
myelinophagia in the affected cerebellar white matter. Right: unaffected parts of same dog (LFB-CEV, 4006). ML =molecular layer, PL = Purkinje cell
layer, GL = granular cell layer, WM=white matter.
doi:10.1371/journal.pgen.1002759.g002
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stress [51,52] We therefore hypothesized that the c.1972T.C
change in SEL1L could lead to dysfunction of the protein complex
and cause ER stress. Disruption of ER homeostasis activates the
unfolded protein response (UPR), which upregulates genes that are
required for cell survival during ER stress [53–57]. We measured
the transcript levels of nine known ER stress responsive genes,
ATF6, CHOP, XBP1, HSPA5, HERPUD1, DNAJB11 (ERdj3),
DNAJC (p58IPK), EDEM1 and HRD1 in cerebellar cortical tissue of
five affected FHs and a control dog. For XBP1, we measured both
the unspliced (XBP1u) and the spliced (XBP1s) transcripts [58–
60]. All tested UPR genes showed increased expression levels in
the affected dogs (Figure 6B). The highest, 14-fold increase was
observed for CHOP, whereas 1.9 to 4.2-fold increases were
observed for the other eight UPR genes. These results are
indicative of ER stress in the affected cerebellar cortex and support
the pathogenicity of the identified SEL1L mutation.
Discussion
We describe here the clinical and histopathological phenotype
of a progressive early-onset cerebellar ataxia in FHs and identify a
missense mutation in the SEL1L gene that segregates with the
recessive disease. The clinical course in FH ataxia is compatible to
the classical canine cerebellar abiotrophy, which has an early-
onset, rapid progression and poor prognosis [16,17,19–
22,25,27,28]. Affected FHs present with a progressive ataxia that
causes significant ambulatory difficulties. The symptoms worsen
rapidly and the affected puppies are euthanized soon after
diagnosis. Cerebellar degeneration is visible in MRI at the age
of 3 months. Histopathological features are consistent with a
premature degeneration of cerebellar cortical PCs, where the PCs
are the primary target of a degenerative pathological process,
followed by secondary changes in other cortical cell layers. We
suggest that the now identified SEL1L mutation (c.1972T.C,
p.Ser658Pro) is the most likely underlying cause in FH ataxia.
Several lines of evidence support SEL1L as the causative gene.
First, SEL1L is the best positional and functional candidate in
the 1.5 Mb disease associated haplotype block. The haplotype
contained five known protein coding genes, which were screened
for mutations. The only coding variant that causes a protein level
change was found in the SEL1L gene. SEL1L shows ubiquitous
expression in adult tissues and is widely expressed during
embryonic development, with intense expression in developing
neural tissue and pancreas [49,61,62]. We confirmed SEL1L
expression in the cerebellar cortex, the affected organ in FH
ataxia.
Second, the SEL1L protein belongs to a disease-relevant
pathway. SEL1L functions in a large protein complex in the
ER, in a cellular process referred to as ER-associated degradation
(ERAD) [38–41]. The ERAD machinery targets terminally
misfolded and unassembled polypeptides which are recognized,
dislocated to the cytoplasm and marked for proteasome-dependent
degradation [55,63,64]. SEL1L is a component in an ERAD
complex that is organized around an E3 ubiquitine ligase, HRD1
[38,40,41,65–67]. Although the precise function of SEL1L is not
known, it is proposed to have an adaptor role and to be involved in
recruiting ERAD substrates to the HRD1 ligase complex, either
directly or via other proteins [39,40,65–67]. ER stress and
impaired protein degradation have been implicated in several
neurodegenerative diseases [52,68,69]. As an indication of acute
Figure 3. Finnish Hound ataxia pedigree. Pedigree shows those affected litters that were used in the study. Disease segregation is consistent
with autosomal recessive mode of inheritance as all affected dogs are born from healthy parents and both sexes are affected. The proportion of
affected puppies is 29%, which is close to expected 25%. Denoted are the clinically and pathologically examined cases and the dogs that were
genotyped for genome-wide analyses. The numbering of litters and puppies refers to the numbering used in Table 1. *In this one litter, the total
number of offspring was unknown.
doi:10.1371/journal.pgen.1002759.g003
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Figure 4. Genetic studies. (A) A Manhattan plot of case-control genome-wide association test performed using 13 cases and 7 unaffected sibling-
controls. (B) Results of the family-based testing on the disease associated chromosome 8. Plotted are single-point linkage analysis LOD scores,
association test p-values and joint analysis p-values. (C) Genotypes at the disease associated locus on CFA8. All cases share a 1.5 Mb homozygous
block, and within this block BICF2P948919 shows complete segregation with the disease. (D) A schematic representation of the seven genes found
on the 1.5 Mb block and of the SEL1L gene structure. SEL1L exons are marked with black boxes and red denotes the untranslated regions (UTRs).
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ER stress in the cerebellar cortex of affected FHs, we show
increased expression of several transcription factors and chaperone
proteins that belong to the ER stress response pathway, UPR.
Increased transcription levels were also found for SEL1L and
HRD1, which are both known to be upregulated in ER stress [70].
However, the highest increase was detected in the expression of a
proapoptotic transcription factor CHOP [71–73]. CHOP is
normally expressed at very low levels but is highly induced in
ER stress [74,75]. Overall, our expression data supports the
pathogenic role of the SEL1L mutation in FH ataxia. There is one
previous report that connects SEL1L to a neurodegenerative
phenotype. A tentative association was found between an intronic
SEL1L SNP and Alzheimer’s disease [76]. However, given the
early-onset and rapid progression of the disease in FHs, our study
indicates that SEL1L has crucial role in the developing brain and
suggests that SEL1L is an unlikely candidate gene for late-onset
neurodegenerative disorders. This is further supported by a
prenatal lethality of Sel1l-deficient mice [77].
Third, the p.Ser658Pro amino acid change hits a highly
conserved residue in an evolutionary conserved repeat motif in the
SEL1L protein. The affected domain is the next to last carboxy-
terminal Sel1-repeat. Unlike the amino-terminal fibronectin type
II domain, which is absent from invertebrate SEL1L orthologues,
the Sel1-repeats are highly conserved across species [49]. The a/
a-helical Sel1-repeats are found in several proteins that function as
adaptors in protein complex formation [78]. Deletion of the two
most carboxy-terminal Sel1-repeat clusters in mammalian SEL1L
have been reported to abolish interactions with HRD1 and other
proteins [40], and recent data suggests that the stabilization of the
mammalian SEL1L depends on HRD1 [79]. Sequence homology-
BICF2P948919 is located on second SEL1L intron and the c.1972T.C mutation on exon 19. (E) Chromatograms of the c.1972T.C mutation in an
affected, a carrier and a wild-type dog.
doi:10.1371/journal.pgen.1002759.g004
Figure 5. SEL1L protein structure and partial sequence alignment. (A) A Schematic representation of the SEL1L protein, which shows the
multi-modular protein structure. The p.Ser658Pro mutation hits one of the C-terminal Sel1-repeats. (B) SEL1L amino acid sequence alignment.
Position of the mutation is conserved in all aligned species except for C. elegans and yeast. The Hrd3-motif, which is positioned five residues
downstream from the Ser658, shows conservation across all aligned species.
doi:10.1371/journal.pgen.1002759.g005
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based prediction programs all indicated a likely damaging effect of
the p.Ser658Pro change. Moreover, there is a considerable
difference in structure between the two amino acids, serine and
proline. The latter possesses a conformationally restricted cyclic
molecular structure, which could interfere with proper protein
folding. Given the role of the Sel1-repeats in protein interactions,
it is possible that the p.Ser658Pro change disrupts SEL1L protein-
protein interactions, for instance with HRD1, compromising the
function of the ERAD complex.
Forth, a mouse model connects Sel1l deficiency to impaired
ER-mediated protein quality control. A recent paper reported
embryonic lethality and signs of systemic ER stress in Sel1l-
deficient mice [77]. Heterozygous mice were normal and fertile
but those that were homozygous for a gene trap mutation between
Sel1l exons 14 and 15, died at mid-gestation, and suffered from
growth retardation and morphological brain abnormalities [77].
Cell lines derived from the mutant mice revealed changes in ER
morphology, hypersensitivity to ER stress inducers, defects in
degradation of unfolded proteins and an impaired protein
secretory pathway [77]. In accordance with our results, several
UPR genes were upregulated in the mutant embryos [77]. The
embryonic lethality of the Sel1l-deficient mice suggests that the
canine mutation is milder and does not abolish all SEL1L
function. The affected FH puppies did not show any gross
morphological abnormalities and seemed to develop normally over
the first few weeks of life. Furthermore, some SEL1L functions
might be complemented by protein isoforms [49,62,80–82].
Amino-terminal SEL1L isoforms that contain a variable number
of Sel1-repeats but lack the carboxy-terminal region, have been
indicated to function in parallel or complementary to the full
length SEL1L in ER stress [81,82].
Although SEL1L is ubiquitously expressed, another explanation
for the cerebellum-restricted pathology may come from the
vulnerability of the cerebellar PCs to ER stress. Various disease
phenotypes indicate that cerebellar PCs are susceptible to undergo
premature degeneration [13,14,33,83,84] and accumulating evi-
dence indicate ER stress specifically as causative in PC pathology
[85–92]. These observations could account for the primary PC
degeneration in affected FHs. In addition to our results on SEL1L
cerebellar expression, a previous study found HRD1 in murine
PCs [93]. It is plausible that a compromised function of the
HRD1-ligase pathway would not be tolerated by ER stress
sensitive PC and would lead to excessive or prolonged ER stress,
triggering apoptosis and neurodegeneration. Whether any path-
ological changes would be seen in other tissues if the affected dogs
were kept alive longer, is not known.
In conclusion, we identify a novel progressive ataxia gene and
link a defective ERAD pathway to an early-onset cerebellar
neurodegeneration. Our study implicates a critical function for the
HRD1-SEL1L-mediated ERAD pathway in the postnatal PC
survival and provides a novel model to investigate the role of the
ER stress in neurodegeneration. SEL1L represents a novel
candidate gene for human ataxias and we have initiated mutation
screenings in childhood phenotypes. Meanwhile, a genetic test has
been offered for FH breeders to identify carriers and to eradicate
the disease from the breed.
Materials and Methods
Ethics statement
All the dogs used in this study were privately-owned pets, and
the genetic and clinical examinations were approved by the
Animal Ethics Committee at the State Provincial Office of
Southern Finland (permits: ESLH-2006-08207/Ym-23 and
ESHL-2009-07827).
Animals and blood samples
EDTA-blood samples were collected from 13 affected FH
puppies that belonged to seven different litters, and from 33
unaffected first-degree relatives. The unaffected relative sample
cohort comprised 13 parent dogs and 20 unaffected full-siblings. A
pedigree was constructed around the affected dogs by using
GenoPro genealogy software (http://www.genopro.com/). FH
population controls (n = 241) and an additional control sample
cohort of 349 dogs from 51 other dog breeds were selected among
samples stored at the Canine DNA Bank located at Biomedicum
Helsinki, Finland. The FH population cohort included random
samples from unaffected FHs that had been collected for instance
at dog shows. Full-siblings were excluded from the population
cohort to obtain a reliable estimate a carrier frequency. The
control cohort from other breeds comprised one dog from two
breeds, two dogs from 38 breeds and 10 to 32 dogs from 11 breeds
Figure 6. Gene expression analysis in the affected cerebellum. (A) The mRNA levels of SEL1L, STON2 and CEP128 in the cerebellar cortex of
five affected dogs compared to a control puppy. These three genes had sequence variants that segregated with the ataxia phenotype. (B)
Endoplasmic reticulum (ER) stress markers are upregulated in the cerebellar cortex of affected animals. The relative mRNA expression levels are
represented as a fold change. Error bars denote the standard error of normalized Ct-values. *p#0.05 **p#0.001 ***p#0.000 (two-tailed t-test p-
values).
doi:10.1371/journal.pgen.1002759.g006
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(Table S3). Puregene DNA Purification Kit (Gentra Systems) was
used to extract genomic DNA from affected dogs and their
relatives. A semi-automated Chemagen extraction robot (Chema-
gen Biopolymer-Technologie AG) was used for the control
samples. Concentration of DNA samples was determined using a
ND-1000 UV/Vis Spectrophotometer (NanoDrop Technologies).
Clinical examinations
General clinical, orthopedical and neurological examinations
were performed on ten ataxic FH puppies that were referred to a
veterinary neurology clinic during December 2006 and September
2008. The examined puppies came from six different litters. One
healthy sibling was examined as a control dog. Neurological
examinations were filmed and are available for retrospective
evaluation. CBC and serum biochemistry profiles (sodium,
potassium, calcium, phosphorus, magnesium, glucose, total
protein, albumin, globulin, blood urea nitrogen, creatinine, total
bilirubin, alanine aminotransferase, aspartate aminotransferase,
alkaline phosphatase, and creatine kinase) were examined on
admission. Brain MRI scanning and CSF sample collection were
performed under general anesthesia. Intramuscular anaesthesia
premedication was carried out with the combination of Medeto-
midine (Domitor, Orion Pharma) 0.02 mg/kg and Butorphanol
(Torbugesic, Scan-Vet) 0.1 mg/kg. Anaesthesia was induced
through intravenous bolus of Propofol (Propofolum, Abbott
Laboratories) 6–8 mg/kg and maintained through inhalation of
Isoflurane (IsoFlo vet, Orion Pharma) and oxygen.
A 0.2 Tesla MRI scanner (VetMR, Esaote) was used to record
T1W and T2W images in transversal and sagittal planes on
animals placed in sternal recumbency. TW1 images were recorded
using 750.0 ms repetition time (TR), 26.0 ms echo time (TE) and a
field of view (FoV) of 1506150, 1606160 and 1706170 mm and
T2W images with 3000.0 ms TR, 90.0 ms TE and 1606160 or
1706170 mm FoV. In all images, slice thickness was 4.0, 4.5 or
5.0 mm and interslice gap 0.4–0.5 mm. T1W images were
repeated immediately after intravenous injection of contrast agent,
gadolinium-diethylenetriaminepenta-acetate (-DTPA) dimeglu-
mine 0.2 mL/kg (0.1 mmol/kg). Two blinded examiners (SC
and JJ) rated the dogs subjectively as affected or healthy based on
cerebellar size, amount of CSF between the cerebellar folia, size of
the fourth ventricle and distance between caudoventral edge of the
cerebellum and foramen magnum. CSF samples were collected
from the cerebellomedullary cistern after the MRI examination.
Total cell count and protein concentration were evaluated from
the CSF samples and considered normal if there were less than five
nucleated cells per microliter and if Pandy reaction was negative.
Affected dogs with compatible clinical signs and MRI findings
were euthanized with owner’s agreement.
Pathological and histological examinations
A complete autopsy was performed on the ten clinically
examined dogs. For one additional puppy, only the brain was
received for examination. The weight of the cerebellum relative to
the total weight of the brain was determined in five dogs. Samples
from the CNS, liver, lungs, spleen, kidney and heart were collected
and fixed in neutral buffered 10% formalin. Sections from the
fixed tissues were embedded in paraffin and processed for light
microscopic examination, using the haematoxylin-eosin (HE)
stain. The CNS was sectioned at nucleus caudatus with cerebral
cortex, hippocampus with temporal cortex, mesencephalon at the
height of the cranial colliculi, cerebellum transversally and
longitudinally with pons and medulla oblongata. Sections from
the CNS were stained with luxol fast blue/cresyl echt violet (LFB-
CEV) to evaluate chromatolysis and myelin loss. An IHC stain for
glial fibrillary acidic protein (GFAP, MCA 1909, Serotec) was used
to assess astrogliosis. IHC staining of spleen, lung and kidney
sections were performed for canine distemper virus (CDV, MCA
1893, Serotec), and sections of spleen were stained for canine
parvovirus (CPV, MCA2064, Serotec).
Candidate gene analysis
Altogether 24 known human and murine ataxia genes were
selected for a microsatellite marker-based candidate gene analysis
(Table S1). Segregation of microsatellite markers was examined in
three nuclear families, comprising six parents, five affected dogs
and three healthy siblings. Allele sizes were determined by
fragment analysis. Human and murine mRNA sequences for the
candidate genes were obtained from the GeneBank database
(http://www.ncbi.nlm.nih.gov/) and the corresponding canine
sequences were identified from the CanFam2.0 annotation using
the BLAT search tool [94]. Microsatellite primers (Table S4) were
designed using Primer 3 (http://frodo.wi.mit.edu/primer3/).
Forward primers were either directly labeled with a fluorescence
dye (HEX or FAM) or alternatively, an M13-tail sequence was
added to the 59-end and used together with a third, FAM-labeled
M13-primer [95]. PCR amplifications were performed using a
PTC-225 Peltier Thermal Tetrad Cycler (Bio-Rad) and a standard
PCR protocol. Reactions that included directly labeled forward-
primers were performed in a reaction volume of 10 ml with 20 ng
of genomic DNA, 1 X PCR buffer, 2.5 mM MgCl2, 0.2 mM
dNTPs, 0.5 mM of forward- and reverse primers and 0.375 units of
AmpliTaq Gold Polymerase (Applied Biosystems). Amplifications
that were performed using the M13-primers were carried out in a
12 ml volume containing 15 ng of genomic DNA, 1 X PCR buffer,
2.1 mM MgCl2, 0.33 mM dNTPs, 0.05 mM M13-tailed forward
primer, 0.25 mM reverse primer, 0.2 mM M13 primer and 1.2
units of Biotools DNA polymerase. Intensity of PCR products was
evaluated from 1% agarose gel stained with 0.5 mg/ml ethidium
bromides (Amresco). Fragment analysis runs were performed on a
3730xl DNA Analyzer (Applied Biosystems). The Peak Scanner
software (Applied Biosystems) was used to determine allele sizes.
Genotype data analysis
Thirteen affected dogs from seven nuclear families and 18
related control dogs were genotyped using Illumina’s Cani-
neSNP20 BeadChip of 22,362 validated SNPs. Healthy control
dogs included 11 obligate disease carrier parents and seven non-
affected siblings (Figure 3). Genotype data was filtered using a SNP
call rate of .95%, an array call rate of .95% and minor allele
frequency of .5%. Based on these criteria, 289 SNPs were
removed for low genotyping efficiency and 6739 SNPs for low
minor allele frequency. Mendel errors were detected in 35 SNPs,
which were removed from analyses. No samples were removed for
low genotyping and no SNPs for significant deviations from the
Hardy-Weinberg equilibrium (p#0.0001). After the filtering steps,
15,299 SNPs remained for analyses. A basic case-control
association test was performed by using the software package
PLINK [36]. Obligate carrier parents were excluded from the
case-control association test and the remaining seven healthy
siblings were used as controls. Genome-wide significance was
ascertained through phenotype permutation testing (n = 100,000).
Pseudomarker program was used to perform family-based testing
on CFA8, which showed genome-wide significant association in
the PLINK analysis [37]. The family-based analyses were
performed under a recessive inheritance model, and included
parametric single-point linkage test, association analysis (LD|Link-
age) and joint analysis (LD+Linkage).
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Mutation screening
Mutation screening of CEP128, TSHR, GTF2A1, STON2 and
SEL1L exons, exon-intron junctions and 59 and 39 UTRs was
performed using samples from two affected dogs and two obligate
disease carriers. Primers (Table S5) were designed by using Primer
3 (http://frodo.wi.mit.edu/primer3/). PCR reactions were carried
out in a total reaction volume of 20 ml with 20 ng of genomic
DNA, 1 X PCR buffer, 2 mM MgCl2, 0.2 mM dNTPs, 0.5 mM of
forward- and reverse primers and 0.5 units of Biotools DNA
Polymerase. PCR amplification was performed using a PTC-225
Peltier Thermal Tetrad Cycler (Bio-Rad) and a standard PCR
protocol. The reaction products were run on a 1% agarose gel
stained with 0.5 mg/ml ethidium bromide (Amresco). PCR
products were purified with ExoSAP-IT (GE Healthcare) and
sequenced using an Applied Biosystems’ 3730xl DNA Analyzer.
Sequence Scanner v1.0 and Variant Reporter v1.0 (Applied
Biosystems) were used to assess sequence quality and identify
polymorphisms. Control sample cohorts were screened by using
Applied Biosystems’ TaqMan chemistry and 7500 Fast Real-Time
PCR instrumentation. The genotyping reactions were carried out
in a 10 ml reaction volume with 1 X TaqMan genotyping assay
(Applied Biosystems), 1 X Taqman Genotyping Master Mix
(Applied Biosystems) and 10 ng of genomic DNA. Primer
sequences for the Taqman assay were 59- CGTAGACTACGA-
GACTGCATTTATTCA -39 for the forward, and 59 - GAT-
TAAACATAGCTTGTGCACTGTGT - 39 for the reverse
primer. Probe sequences were 59 - TGCTGCTCAGATGCTA -
39 and 59 - TGCTGCTCAGGTGCTA - 39, labeled with VIC
and FAM, respectively.
Bioinformatic analysis
Pfam protein families database (http://pfam.sanger.ac.uk/) [96]
and the SMART tool (http://smart.embl-heidelberg.de/) [97,98]
were used to confirm the protein domain structure of canine
SEL1L. The ClustalW2 algorithm was used to compose a multiple
sequence alignment to examine cross-species conservation (http://
www.ebi.ac.uk/Tools/clustalw2/). Three sequence homology-
based software tools, PANTHER (http://www.pantherdb.org/
tools/) [99,100], PolyPhen-2 (http://genetics.bwh.harvard.edu/
pph2/) [101] and SIFT (http://sift.jcvi.org/) [102–104], were
used to predict the potential functional impact of the identified
non-synonymous variant. The PANTHER tool has a score range
from 0 to about 210, with a cutoff for functional significance at
#23. The PolyPhen-2 score ranges from 0 to 1, with the
threshold for probably damaging at 0.85. The SIFT score ranges
from 0 to 1, and substitutions are predicted to affect function if the
score is #0.05.
Tissue samples and mRNA experiments
Tissue samples were collected from the cerebellar cortex of five
affected puppies immediately after euthanasia. Samples were
stabilized in RNAlater reagent (Ambion, Inc) and stored in
280uC. Total mRNA extraction was performed using the RNeasy
Mini Kit (Qiagen) with a DNase I digestion step included (RNase-
Free DNase Set, Qiagen). Concentration of total RNA was
measured using a ND-1000 UV/Vis Spectrophotometer (Nano-
Drop Technologies). Reverse-transcriptase (RT) -PCR was carried
out on equal amounts of RNA in each sample by using the High
Capacity RNA-to-cDNA Kit (Applied Biosystems). A cerebellar
control sample was obtained from an 11 days old Saluki puppy
that was put down due to a peritoneo-pericardial hernia.
SEL1L mRNA sequencing primers (Table S5) and all qPCR
primers (Table S6) were designed using Primer 3 (http://frodo.wi.
mit.edu/primer3/). If possible, forward and reverse primers were
positioned in different exons to help control for genomic DNA
contamination. SEL1L mRNA amplification reactions and se-
quence analysis were performed as described for mutation
screening. Real-time quantitative PCR was performed by using
the Applied Biosystems’ 7500 Fast Real-Time PCR instrumenta-
tion and Roche’s FastStart Universal SYBR Green Master. A total
reaction volume of 20 ml was used, together with a 0.25 mM
concentration of forward- and reverse primers. Two house-
keeping genes, GAPDH and YWHAZ, were used as normalization
controls, and triplicate samples were used for all reactions. The
efficiency of the qPCR reactions was calculated from a five-point
dilutions series. No significant differences were detected in the
efficiencies between the house-keeping and target reactions, and
the comparative DDCt-method could be used to determine relative
expression differences [105]. Statistical significance of the
expression differences was calculated by using the Student’s t-test
on normalized mean cycle threshold (Ct) -values. PASW Statistics
18 software (IBM) was used to perform the statistical tests.
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Video S1 Gait. Video shows the normal gait of an unaffected
three months old Finnish Hound puppy and the altered gait of two
affected similarly aged puppies. Note the difficulty of the affected
puppies to control limb movements (ataxia), particularly in the
hind limbs. Affected puppies present with swaying of the whole
body (truncal ataxia) and abnormal postures, which are caused by
the coordination difficulties. The puppies struggle with movement
coordination, especially when the direction or speed of the
movement changes or when the movement is initiated or stops
abruptly. This is caused by inability to control the distance and
scale of the movement (dysmetria), which leads to too short or too
long steps.
(WMV)
Video S2 Postural reactions. Video shows postural reactions in
an unaffected and affected puppy. Postural reactions were
examined by testing the puppies’ proprioception (overknuckling),
hopping reaction and postural thrust reaction, and by performing
the wheelbarrowing test (tests appear in this order in the video).
Proprioceptive positioning is normal in both the healthy and
affected puppy as cerebellum is not involved in this reaction. In the
other three tests, the affected puppy shows delayed initiation and
dysmetria when it is stepping or jumping.
(WMV)
Video S3 Intention tremor. Video shows four affected puppies
that suffer from intention tremor, which is a type of tremor never
seen in healthy puppies. The tremor is predominantly seen when
movement is initiated (first puppy) or when there is an intention to
eat or smell (other three puppies). The amplitude of the intention
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tremor of the head varies from low (second and third puppy) to
high (fourth puppy).
(WMV)
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